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Abstract 
Background: Multidrug resistance is a global health issue. Hence integration of traditional medicine like honey and 
modern medicine could be a best option in the treatment of patients infected with drug resistant bacteria. Despite 
the multi floral and huge honey production in the region, there are no studies that evaluate the antibacterial activity 
of honey against multidrug resistant bacteria.
Objective: To evaluate the antibacterial activity of honey against multidrug resistant human pathogenic bacterial 
isolates of wound and ear infections.
Methods: Red and white honeys were obtained from three districts Eastern Zone of Tigray namely Temben, Atsbi 
and Samre. The antibacterial potential of these honeys was determined against multidrug resistant isolates of clini-
cal isolates of bacterial species of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, 
Coagulase negative Staphylococcus, Streptococcus pyogenes and Klebsiella pneumonia, and five controls bacterial 
using tube dilutions methods. Undiluted and twofold serial dilutions of honeys were tested to determine minimum 
inhibitory concentration (MIC) using broth tube dilution methods through visual inspection and minimum bacteri-
cidal concentration (MBC) was determined by sub-culturing tubes showing no visible sign of growth/turbidity in MIC.
Results: The mean MIC of red honeys for control and test bacteria was 7.7–8.9 and 12.6–17.9 % (v/v) respectively. 
Whilst the MIC of white honey was 12.2–12.5 % (v/v) for control and 16.1–27.7 % (v/v) for test bacteria. Mean MBC of 
red honeys for control and test isolates was from 25–40 to 30.4–62.5 % (v/v) respectively, and 40–55 and 60.7–75 % 
(v/v) for white honeys. Honey collected from Samre area has shown better antibacterial activity than other sites. Simi-
larly red honeys from all areas were found to have better antibacterial activity against the multidrug bacteria than the 
white honey. Over all the MIC and MBC of all isolates was between 6.25–50 and 12.5–100 % (v/v) respectively.
Conclusion: Red honey from all sites showed better antibacterial activity than the white honey. Likewise, honey from 
Samre area showed better antibacterial activity than Temben and Atsbi districts. All collected honeys showed varied 
bacteriostatic and bactericidal activities, and none of the isolates was resistant to tested honeys.
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Background
The use of traditional and herbal medicine to treat infec-
tions was practiced since the origin of mankind, and it 
was the only option to treat before the ear of antibiot-
ics (Jawad 2011). A variety of plants and their extracts 
have been used for the treatment requiring antimicro-
bial activity, and one of the popular natural antimicrobial 
substances described in the ancient medicine is honey 
(Mandal and Mandal 2011).
Honey is the natural sweet substance obtained from the 
secretions of the living parts or excretions of plants which 
the honey bees (Apis mellifera) collect and store (Moore 
et  al. 2001). Though honey is used widely in traditional 
medicine, its use in modern medicine is limited (Geen-
wood 1993). Honey is used for the treatment of many 
infections, and also used effectively as wound dressing 
including surgical wounds, burns and skin ulcers. Mainly 
because it speeds up the growth of new tissues and help 
to heal the wound, reduces pain and odor quickly (Lusby 
et al. 2002).
The high osmotic nature and naturally low pH (3.2–4.5) 
(Kwakman and Zaat 2012), ability to produce hydrogen 
peroxide, which plays a key role in the antimicrobial 
activity of honey (Kacaniova et al. 2011) and phytochemi-
cal factors such as tetracycline derivatives, peroxides, 
amylase, fatty acids, phenols, ascorbic acid, terpenes, 
benzyl alcohol and benzoic acid (Bogdanov 1984; Shears 
2000) are factors attributed honey to have potent bac-
tericidal and bacteriostatic activity against pathogenic 
bacteria.
Studies have shown the broad-spectrum antibacterial 
effect of honey for several bacteria including, aerobes and 
anaerobes and gram-positive and gram negative (Allen 
et  al. 2000; Kingsley 2001; Al-Waili et  al. 2005; Cooper 
et  al. 2002). Most human pathogenic bacteria causing 
wound infections such as Staphylococcus aureus, Pseu-
domonas aeruginosa, Escherichia coli and Streptococcus 
pyogenes were found to be sensitive to honey (Visavadia 
et al. 2006). Concentration of honey used and the nature 
of the bacterial isolate (Kacaniova et  al. 2011); origin 
and method of honey processing (Molan 1992) are fac-
tors that affect the antibacterial activity of honey. This 
variation in the antibacterial potency of different types 
of honeys hampered its acceptance in modern medicine 
(Kwakman 2008).
Over and indiscriminate use of antibiotics has led to 
the emergence of multidrug resistant bacterial strains, 
a global public health problem (Kacaniova et  al. 2011; 
Mandal et  al. 2009). To solve this challenge, alternative 
antimicrobial strategies like plants and plant-based prod-
ucts such as honey have currently got more attention 
(Basualdo et al. 2007; Mulu et al. 2004).
There are few researches conducted in Ethiopia regard-
ing the antimicrobial potential of honey (Ahmed et  al. 
2014; Getaneh et  al. 2013; Mulu et  al. 2004; Mogessie 
1994). However, research papers explaining both the 
antimicrobial potential on multidrug resistant bacteria 
and variations in the antimicrobial potential of different 
honeys are limited. This study, therefore, not only high-
lights the antibacterial potential of the honeys but also 
gives information about the variations in the antibacte-
rial potential of different honeys by color and districts in 
Eastern Zone of Tigray Regional state against multidrug 
resistant bacteria isolates.
Methods
Study design, study area and period
Experimental study design method was conducted in 
Mekelle University, College of Health Sciences, Ayder 
Referral and Teaching Hospital from January to May 2015.
Specimen collection
Swabs from ear discharge and post surgical wounds were 
collected from patients attended the ear, nose and throat 
(ENT) clinic and surgical wards. Specimens were then 
transported to the microbiology laboratory for bacterio-
logical analysis and experimental test.
Isolation and identification of bacteria
Collected swabs were inoculated on MacConkey agar, 
Blood agar and Manitol Salt agar and incubated at 37 °C 
for 18–24 h aerobically. Grown isolates were then identi-
fied by their colony morphology, Gram staining reaction, 
and Biochemical tests including Catalase test, Coagulase 
test, Triple Sugar Iron agar (TSI) (OXOID, UK), Citrate 
utilization test (BBL™), Urease test (BBL™), Motility 
Indole Lysine (MIL) [BBL™] and Optochin test using the 
standard procedure for bacterial identification (Clinical 
and Laboratory Standards Institute 2013). Accordingly 
the following bacteria were identified from the clinical 
specimens isolates S. aureus (ear discharge), P. mirabilis 
(ear discharge), P. aeruginosa (wound), S. pyogenes (ear), 
K. pneumoniae (wound) E. coli (wound) and Coagulase 
negative staphylococci(wound) for the experimental 
study. Control strains [American Type Culture Collection 
E. coil ATCC 25922, S. aureus ATCC 25923, P. aerugi-
nosa ATCC 27813, K. pneumoniae, P. mirabilis obtained 
from Ethiopia Health and Nutrition Research Institute 
(EHNRI)] were used as a quality control.
Identification of multidrug bacterial isolates
Antibiotic susceptibility pattern of the isolated bacte-
ria was done to identify multidrug resistant ones for 
the experimental study on Muller-Hinton agar (Oxoid, 
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England) using disk diffusion method. Tetracycline 
(30 μg), penicillin G (10 μg), erythromycin (15 μg), gen-
tamicin (10 μg), ciprofloxacin (5 μg), norfloxacin (10 μg), 
trimethoprim–sulfamethoxazole (25  μg), nitrofurantoin 
(300 µg), doxycycline (30 µg), ceftriaxone (30 μg), ampi-
cillin (10 μg) and amoxicillin clavulanic acid (10 μg) (all 
Oxoid, England) were used to test the resistance pattern. 
Multidrug resistance was defined as non susceptible to 
≥1 agent in ≥3 antimicrobial categories as per the rec-
ommendation of Magiorakos et al. (2012).
Honey collection and processing
Six honey samples (three red and three white) from three 
districts were collected from local markets in sterile 
screwed-cup container and kept in cool and dry place in 
the laboratory for processing. Honey samples were first 
filtered with a sterile mesh to remove the debris and were 
stored at 2–8 °C for further use.
Preparation of bacterial isolates
From the multidrug resistant colonies, three to five pure 
colonies were picked from each isolates with an inoculating 
wire loop, suspended in 4–5 ml of nutrient broth and incu-
bated at 37 °C for 24 h. The bacteria suspension then was 
diluted with sterile distilled water until it matches the tur-
bidity of 0.5 Mc Far land Standards (105–106 CFU/ml). The 
resulting suspensions were further diluted 1:100 in sterile 
nutrient broth to set inoculums density of 1 × 104  CFU/ml 
according the set procedure (Kacaniova et al. 2011).
MIC determination
The minimum inhibitory concentration of the hon-
eys was determined using broth tube dilution method 
according to Kacaniova et  al. (2011) procedure. Briefly, 
ten sterile test tubes were placed in rack, labeled each 
1 through 8. Honey control tube (HC) and growth con-
trol tube (GC) were used as a quality control. One ml of 
freshly prepared nutrient broth was added to each tube, 
sterilized and cooled. Then one ml of undiluted honey 
solution 100 % was added to test tube number 1 and HC 
with a sterile micropipette and tips. Then twofold serial 
dilution was performed by transferring 1  ml undiluted 
honey into the second tube with separate sterile micro-
pipette and tips and vortexed for homogenization. After a 
through mixing, 1 ml was transferred with another sterile 
micropipette from tube 2 and tube 3. These procedures 
continued until eighth tube with a dilution of 1:128 was 
reached and finally 1  ml was taken and discarded from 
tube 8. The GC tube received no honey was served as a 
growth control while the HC tube received no bacterial 
inoculums was served as a honey control.
Except the HC tube, each tube was inoculated with 
1 ml of the culture of respective prepared organism. The 
whole procedures were repeated for all the organisms 
tested to each of the honeys. Tubes were then incubated 
at 37  °C for 24 h and observed by visual inspections for 
the presence and absence of growth (turbidity).
MBC determination
To determine the MBC, incubated tubes showing no 
visible sign of growth/turbidity in MIC, were sub-cul-
tured onto sterile nutrient agar plates by streak plate 
method and incubated at 37 °C for 24 h aerobically. The 
least concentration of honey that did not show growth 
of test organisms was considered as the MBC (Kacan-
iova et  al. 2011). Then inoculated plates were scored 
as bactericidal if no growth; bacteriostatic if there is 
light to moderate growth and no antibacterial activity 
if there is heavy growth according the record of Payveld 
(1986).
Pre test and data quality control
Pretest was conducted to check the method with qual-
ity control organisms. Sensitivity test was done against 
honey of different concentration and bacteria for its 
reliability and validity before it was used for actual 
experiment.
Ethical consideration
The study was approved and ethically cleared by the 
Research and Ethical Review Committee of Mekelle 
University, College of Health Sciences (Ref. No: ERC 
0459/2015). Written informed consent was obtained 
from each participant. Result of the bacterial and antimi-
crobial resistance profile of the bacteria were communi-
cated with doctors in the ENT clinic and surgical wards 
during the study to help the patients.
Results
The bacteriostatic activity of red honey from Atsbi area 
against P. aeruginosa, CoNS, E. coli and K. pneumoniae 
was 25 % (v/v), whereas white honey from the same area 
showed bacteriostatic activity against CoNS and P. aer-
uginosa at (50 % v/v), K. pneumoniae and E. coli at (25 % 
v/v), and S. aureus and P. mirabilis at (12.5  % v/v). The 
MIC of red honey from Temben area showed bacterio-
static activity at 6.25 % v/v for S. aureus and S. pyogenes, 
12.5 % v/v for P. mirabilis, CoNS and E. coli, and 25 % for 
K. pneumoniae and P. aeruginosa. Mean MIC of 50 % was 
seen by the white honey of Temben for K. pneumoniae, P. 
aeroginosa and CoNS. Red and white honeys from Samre 
area were bacteriostatic at 12.5  % v/v for E. coil, CoNS 
and S. aureus, and 25  % v/v for K. pneumoniae. Over 
all, the mean MIC of all honeys for all tested multidrug 
resistant bacteria in this study was from 12.6 to 27.7  % 
v/v (Table 1).
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The bactericidal activity of red honey from Atsbi area 
against P. aeruginosa, CoNS, E. coli and K. pneumoniae 
was (50  % v/v); whereas the MBC of white honey from 
the same area showed bactericidal activity at (100 % v/v) 
for CoNS, K. pneumoniae and P. aeruginosa. Both red 
and white honeys from Temben area were bactericidal 
Table 1 MIC% (v/v) of  various honey samples against  multidrug resistant bacterial isolates in  Ayder Referral Hospital, 
January–May 2015
NB. TR and TW Temben red and white, SR and SW Samre red and white, and AR and AW Atsbi red and white
Honey dilutions
Test bacteria Net (1) 1/2 1/4 1/8 1/16 1/32 1/64 1/128 Areas MIC% (v/v)
S. aureus − − − − − + + + TR 6.25
P. mirabilis − − − − + + + + TR 12.5
P. aeruginosa − − − + + + + + TR 25
CoNS − − − − + + + + TR 12.5
S. pyogenes − − − − − + + + TR 6.25
K. pneumoniae − − − + + + + + TR 25
E. coli − − − − + + + + TR 12.5
S. aureus − − − − − + + + TW 6.25
P. mirabilis − − − _ + + + + TW 12.5
P. aeruginosa − − + + + + + + TW 50
CoNS − − + + + + + + TW 50
S. pyogenes − − − − − + + + TW 6.25
K. pneumoniae − − + + + + + + TW 50
E. coli − − − − + + + + TW 12.5
S. aureus − − − − + + + + SR 12.5
P. mirabilis − − − − − + + + SR 6.25
P. aeruginosa − − − − + + + + SR 12.5
CoNS − − − − + + + + SR 12.5
S. pyogenes − − − − − + + + SR 6.25
K. pneumoniae − − − + + + + + SR 25
E. coli − − − − + + + + SR 12.5
S. aureus − − − − + + + + SW 12.5
P. mirabilis − − − − + + + + SW 12.5
P. aeruginosa − − − + + + + + SW 25
CoNS − − − − + + + + SW 12.5
S. pyogenes − − − − + + + + SW 12.5
K. pneumoniae − − − + + + + + SW 25
E. coli − − − − + + + + SW 12.5
S. aureus − − − − + + + + AR 12.5
P. mirabilis − − − − − + + + AR 6.25
P. aeruginosa − − − + + + + + AR 25
CoNS − − − + + + + + AR 25
S. pyogenes − − − − − + + + AR 6.25
K. pneumoniae − − − + + + + + AR 25
E. coli − − − + + + + + AR 25
S. aureus − − − − + + + + AW 12.5
P. mirabilis − − − − + + + + AW 12.5
P. aeruginosa − − + + + + + + AW 50
CoNS − − + + + + + + AW 50
S. pyogenes − − − − − + + + AW 6.25
K. pneumoniae − − − + + + + + AW 25
E. coli − − + + + + + + AW 25
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for CoNS, K. pneumoniae and P. aeruginosa at (100  % 
v/v), and red and white honey from Temben killed S. 
aureus at (50 % v/v) and (100 % v/v) respectively. MBC of 
both red and white honeys form Samre area killed E. coli, 
S. aureus, CoNS and P. aeruginosa at (50 % v/v). Over all 
the mean MBC of all honeys of tested multidrug resistant 
bacteria was from 30.4 to 75 % v/v (Table 2).
The bacteriostatic activity of red and white honeys 
from Temben area for most control bacteria was from 
6.25 to 12.5 % v/v. However, the MIC for K. pneumoniae 
Table 2 MBC% (v/v) of honey against multidrug resistant bacteria in Ayder Referral Hospital, January–May 2015
−, no growth (bactericidal); +, light growth, ++, moderate growth (bacteriostatic); +++, heavy growth (no antibacterial potential)
Honey dilutions
Test bacteria Net (1) 1/2 1/4 1/8 1/16 Areas MBC
S. aureus − − + ++ +++ TR 50
P. mirabilis − − − − ++ TR 12.5
P. aeruginosa − + ++ +++ +++ TR 100
CoNS − + ++ +++ +++ TR 100
S. pyogenes − − + ++ +++ TR 25
K. pneumoniae − + ++ +++ +++ TR 100
E. coli − − + ++ +++ TR 50
S. aureus − − + ++ +++ TW 50
P. mirabilis − − − ++ +++ TW 25
P. aeruginosa − + ++ +++ +++ TW 100
CoNS − + ++ ++ +++ TW 100
S. pyogenes − − − ++ +++ TW 25
K. pneumoniae − + ++ +++ +++ TW 100
E. coli − − + ++ ++ TW 50
S. aureus − − + ++ ++ SR 50
P. mirabilis − − − ++ +++ SR 25
P. aeruginosa − − + ++ +++ SR 50
CoNS − − + ++ +++ SR 50
S. pyogenes − − − + ++ SR 25
K. pneumoniae − − + ++ +++ SR 50
E. coli − − + ++ +++ SR 50
S. aureus − − + ++ +++ SW 50
P. mirabilis − − + ++ +++ SW 50
P. aeruginosa − − + ++ +++ SW 50
CoNS − − + ++ +++ SW 50
S. pyogenes − − + ++ +++ SW 50
K. pneumoniae − + ++ +++ +++ SW 100
E. coli − − + ++ +++ SW 50
S. aureus − − − + ++ AR 25
P. mirabilis − − − − ++ AR 12.5
P. aeruginosa − − + ++ +++ AR 50
CoNS − − + ++ +++ AR 50
S. pyogenes − − − − ++ AR 12.5
K. pneumoniae − − + ++ +++ AR 50
E. coli − − + ++ +++ AR 50
S. aureus − − + ++ +++ AW 50
P. mirabilis − − − − ++ AW 12.5
P. aeruginosa − + ++ +++ +++ AW 100
CoNS − + ++ +++ +++ AW 100
S. pyogenes − − + ++ +++ AW 25
K. pneumoniae − + ++ +++ +++ AW 100
E. coli − − ++ +++ +++ AW 50
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(25 % v/v) was relatively higher than the other bacteria. 
All control bacteria except P. aeruginosa (25 % v/v), the 
bacteriostatic activity for honeys from Atsibi and Samre 
district was in the range of 6.25–12.5 % v/v. The concen-
tration of Temben honey that killed the control bacteria 
was from 25 to 100  % v/v. Whereas honeys from Atsbi 
and Samre areas was from 25 to 50  % v/v. Red honey 
from Samre and Atsbi areas showed better antibacte-
rial activity at lower concentration than the white hon-
eys from the same areas. P. aeruginosa was completely 
killed at a higher concentration, 100 % v/v and relatively 
showed more resistant than the other control bacteria 
for all honeys in this study. In general the mean MIC and 
MBC of the tested honey against the control bacteria was 
from 7.7–12.6 to 25–55 % v/v respectively (Table 3).
Discussion
The MIC and MBC value in this study indicated that all 
tested honeys have potential bactericidal and bacterio-
static activities against both control and test multidrug 
bacteria. This was similar to other studies conducted 
elsewhere (Allen et al. 2000; Getaneh et al. 2013; Ahmed 
et  al. 2014). The finding of our current study indicated 
that S. pyogenes and S. aureus were completely inhib-
ited at low concentration of honeys. This result was sup-
ported by the study finding of Kingsley who conducted 
study on the use of honey in the treatment of infected 
wound (Kingsley 2001).
The percentage by volume of honeys to completely 
prevent growth of S. aureus, S. pyogenes, E. coli and P. 
mirabilis was in the range of 6.25–12.5  % v/v, and for 
P. aeruginosa 12.5–50 % v/v. In contrary to this, a study 
conducted in Ethiopia has shown that the percent-
age by volume of honey to completely prevent growth 
of E. coli, S. aureus and P. mirabilis to be 6.5 % v/v and 
for P. aeruginosa 7.5 % v/v (Ahmed et al. 2014) which is 
lower concentration than our result. Another study by 
Willix has also found that the % (v/v) of Manuka honey 
to completely prevent growth for S. aureus, S. pyogenes, 
E. coli, P. mirabilis and P. aeruginosa was 1.8, 3.6, 6.0, 6.3 
and 10.8 respectively (Willix et al. 1992). This difference 
in the antibacterial activity of honeys over place might 
be due to the difference in the species of bees (Moges-
sie 1994) and the differences in the test methods used 
and test organisms, where in our case we used multidrug 
resistant bacteria.
Study done in Ireland on Tazma honey have found 
12.5  % v/v of MBC for Methicillin resistant S. aureus 
(MRSA), E. coli and P. aeruginosa (Cooper et  al. 1999), 
and studies done from Ethiopia (Getaneh et  al. 2013; 
Mogessie 1994) on the antibacterial activity of Tazma 
honey on MRSA bacteria have shown from 10 to 11.5 % 
v/v. This supports the idea that there is variation in the 
antimicrobial activities of honey by the source of flower 
and type of honey.
In our study red honeys from all sites showed better 
antibacterial activity at lower MIC and MBC for both 
control and test bacteria than the white honey, and this 
was in tandem to the study by Getaneh from Ethiopia 
(Getaneh et al. 2013). This was inline with the idea that 
color and consistency of honey is affected by the source 
of flower also by variables such as weather and climatic 
changes (Cooper et al. 1999). The difference of anti bac-
terial activity of honeys by color could also due to the 
difference in phenolic content of the honeys, which has 
strongly relation with its antioxidant activity of bacteria 
(Kek et al. 2014; Bertoncelj et al. 2007).
Our study revealed that S. aureus, S. pyogenes, E. coli 
and P. mirabilis, were more sensitive at lower MIC and 
MBC of honey than the P. aeruginosa, K. pneumoniae 
and CoNS. This was supported by result of Getaneh et al. 
from Ethiopia who conducted research on the in  vitro 
assessment of the antimicrobial effect of Ethiopian multi 
flora honey on MRSA (Getaneh et  al. 2013). Possible 
Table 3 The mean MIC and MBC of various honey samples against control bacterial isolates in Ayder Referral Hospital, 
January–May 2015 (% (v/v))
RMIC Red MIC, WMIC White MIC
Bacteria Sites of honey collection
Temben area honey Atsbi area honey Samre area honey
RMIC RMBC WMIC WMBC RMIC RMBC WMIC WMBC RMIC RMBC WMIC WMBC
S. aureus 6.25 50 12.5 50 6.25 25 12.5 50 12.5 12.5 6.25 50
E. coli 6.25 50 12.5 50 6.25 50 6.25 50 6.25 25 6.25 25
P. aeruginosa 12.5 50 12.5 100 12.5 25 25 50 12.5 50 25 50
K. pneumoniae 12.5 25 25 25 12.5 25 12.5 25 6.25 25 12.5 25
P. mirabilis 6.25 25 12.5 50 6.25 25 6.25 25 6.25 12.5 6.25 50
Mean 8.9 40 12.5 55 8.9 30 12.2 40 7.7 25 12.6 40
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reason for these variations between bacteria response to 
honeys might be due to difference in their cellular organ-
ization of the bacteria and the variation in honeys. The 
bactericidal activity of the honeys for all tested isolates 
in this study was found to be between 50 and 100 % v/v 
concentration. This was comparable to other research-
ers from other palaces (Kingsley 2001; Ahmed et  al. 
2014). The bactericidal concentrations of honey against S. 
aureus in our study was between 50 and 100 %. This con-
centration was higher than the finding of other research-
ers (Molan 1992; Ahmed et  al. 2014; Molan and Betts 
2000).
Pseudomonas aeruginosa was reported to be resistant 
to honey by Efem (1988); in contrary to this result how-
ever, the bacteria was sensitive to all honeys tested in this 
study, though at it was a bit at higher concentration than 
the other bacteria. Our result was also supported by the 
study done in other part of Ethiopia (Ahmed et al. 2014). 
The high resistance P. aeruginosa to honeys could be due 
to the low permeability of its cell wall, genetic capacity to 
express resistant mechanisms and mutation in chromo-
somal genes which regulate resistance genes (Allen et al. 
2000).
Both red and white honeys from all areas in this study 
have shown antibacterial activity against K. pneumo-
niae. This was in line with the report by other research-
ers (Allen et  al. 2000; Anyanwu 2011; Subrahmanyam 
1991). Our result was however, in contrast with studies 
by Ahmedet et  al. from Ethiopia (Ahmed et  al. 2014) 
and Olawuyi et  al. (2010) who studied on antibacterial 
activities of honey from different location and reported 
no bactericidal activity against K. pneumoniae. The vari-
ations in sensitivity could be attributed to differences in 
growth rate and lower cell wall permeability of patho-
gen, nutritional requirements, temperature, inoculums 
size and difference in honeys and the test method used 
(Molan and Betts 2000).
In general honeys tested from the three different areas 
showed varied bacteriostatic and bactericidal activities 
against the tested multidrug resistant bacteria. However, 
pharmacological standardization and clinical evaluation 
on the effect of honey are essential before using honey as 
a preventive and curative measure to common diseases 
related to the tested bacterial species. This bacteriostatic 
and bactericidal activity was different by sites of collec-
tion and colour of the honeys. Honey from Samre area 
showed relatively better bacteriostatic and antibacterial 
activity than Temben and Atsbi districts. This could be 
due to the variations in hydrogen peroxide, crops and 
vegetation’s in these districts available for honeybees to 
make honey. Both control and test K. pneumoniae and P. 
aeruginosa were inhibited at relatively higher concentra-
tion of honey than the other bacteria in this study. This 
might be related to nature of the bacteria i.e. low per-
meability of cell wall, genetic capacity to express resist-
ant mechanisms and mutation in chromosomal genes 
which regulate resistance genes. Red honeys in this study 
showed better anti bacterial activity against both control 
and test bacteria than the white honeys.
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